Skip to main content

Table 1 Demographic and clinical characteristics of the patients in this study according to their survival status at 7th day after receiving extracorporeal membrane oxygenation support

From: Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach

Variable

Survival

Death

P value

Sample size (n)

32 (69.6 %)

14 (30.4 %)

 

Age (years) (n = 46)

51.5 (41.5–58.0)

54.7 (48.2–68.2)

0.118

Gender

  

1.000

 Male (n = 35)

24 (68.6 %)

11 (31.4 %)

 

 Female (n = 11)

8 (72.7 %)

3 (27.3 %)

 

Risk factors

 Hypertension (n = 21)

14 (43.8 %)

7 (50.0 %)

0.755

 DM (n = 13)

7 (21.9 %)

6 (42.9 %)

0.171

 CAD (n = 11)

6 (18.8 %)

5 (35.7 %)

0.269

 Smoking (n = 9)

7 (21.9 %)

2 (14.3 %)

0.701

 Dialysis (n = 5)

1 (3.1 %)

4 (28.6 %)

0.078

 Pre-ECMO CPR (n = 13)

10 (31.3 %)

3 (21.4 %)

0.724

 CPR during ECMO (n = 20)

11 (34.4 %)

9 (64.3 %)

0.105

Diagnosis

 AMI (n = 24)

16 (50.0 %)

8 (57.1 %)

0.754

 DCMP (n = 12)

7 (21.9 %)

5 (35.7 %)

0.467

 Myocarditis (n = 6)

6 (18.8 %)

0 (0.0 %)

0.157

 Other (n = 4)

3 (9.4 %)

1 (7.1 %)

1.000

Heart rate (BPM) (n = 42)

116 (88–138)

96 (66–121)

0.196

Systolic blood pressure (mmHg) (n = 40)

90 (74–101)

93 (76–113)

0.902

Diastolic blood pressure (mmHg) (n = 40)

57 (47–67)

53 (44–64)

0.435

pH (n = 45)

7.41 (7.30–7.48)

7.23 (7.13–7.39)

0.066

PaCO2 (mmHg) (n = 45)

32 (23–39)

35 (27–46)

0.455

PaO2 (mmHg) (n = 45)

83 (56–156)

108 (60–222)

0.313

HCO3 (mmol/L) (n = 45)

19.3 (15.9–24.0)

17.6 (12.7–19.3)

0.107

Lactate (mmol/L) (n = 43)

6.7 (3.0–9.7)

10.9 (3.3–18)

0.260

Inotropic equivalent (μg/kg/min) (n = 34)

17.5 (8.2–25.2)

23.3 (18.7–34.4)

0.077

WBC (K/µL) (n = 46)

12.9 (8.7–15.4)

12.3 (9.1–18.4)

0.645

Granulocytes (% of total WBC) (n = 46)

72.8 (40.1–82.1)

60.0 (42.2–80.8)

0.856

Lymphocytes (% of total WBC) (n = 46)

17.3 (9.0–51.5)

34.2 (11.1–50.1)

0.612

Monocytes (% of total WBC) (n = 46)

4.0 (3.2–6.6)

3.9 (2.8–6.4)

0.772

CD14+ CD16+ (% of monocytes) (n = 46)

64.4 (46.4–82.2)

60.7 (43.7–71.6)

0.314

  1. Values are medians with inter-quartile ranges for continuous data and frequency (percentage,  %) for categorical data. The listed P values of statistical tests were calculated using Mann–Whitney U test for continuous data and the Χ 2 or Fisher’s exact test for categorical data
  2. DM diabetes mellitus, CAD coronary artery disease, CPR Cardiopulmonary resuscitation, AMI acute myocardial infarction, DCMP dilated cardiomyopathy, BPM beat per minute, WBC white blood cell
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us